About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Found 331 record(s)
Req # A-2022-000906
Across all Information Technology (IT) professional services contracts that were active during the 2021-2022 fiscal year: the HIGHEST per diem; the LOWEST per diem; the AVERAGE per diem across all of these contracts.Organization: Health Canada
April 2023
Req # A-2022-001025
All documents related to the amalgamation and transfer of the Sioux Lookout Zone Hospital, finalized in the “1997 Sioux Lookout Four Party Hospital Services Agreement” or “1997 Four Party Agreement” negotiated between Nishnawbe Aski Nation (NAN), the municipality of Sioux Lookout, the Province of Ontario, and the Government of Canada. Date range January 1, 1992 to December 31, 2005.Organization: Health Canada
April 2023
Req # A-2022-001042
Submission components for Polymyxin B for Injection United States Pharmacopeia (USP) Drug Identification Number (DIN) 02375893 Submission control 143565: Cover Letter; M1.4.2 Comprehensive Summary Bioequivalence; M1.6.1 Comparative Bioavailability; M2.1 Table of Contents; M2.2 Introduction; and Health Canada Reviewer notes. Please include only electronic documents.Organization: Health Canada
April 2023
Req # A-2022-001194
All correspondence between the Patented Medicine Prices Review Board (PMPRB) and Deputy Minister of Health pertaining to the October 2022 revised draft Guidelines and the resignation of the PMPRB Acting Chairperson.Organization: Health Canada
April 2023
Req # A-2022-001205
The inspection document(s) listing the Inspector’s detailed observations, conditions found, and any follow-up expected by Health Canada for the human drugs drug establishment licence Good Pharmacovigilance Practices (GVP) re-inspection of the AstraZeneca Canada facility (Site A) on Middlegate Rd, Mississauga, Ontario, with the inspection start date of 05/17/2021. Reference Number 503026.Organization: Health Canada
April 2023
Req # A-2022-001226
The Privacy Breach/Incident Tracker from January 1, 2020 to December 14, 2022 for both Health Canada and the Public Health Agency of Canada.Organization: Health Canada
April 2023
Req # A-2022-001308
The initial cover letter indicating the brand name of the reference drug product and the dosage form of the generic drug in Health Canada's list of Generic Drug Submission Under Review for the medicinal ingredient: Palbociclib, Amphotericin B and Budesonide. The screening acceptance letter from Health Canada to the generic drug manufacturer confirming completion of screening of the Abbreviated New Drug Submission (ANDS) for Palbociclib, Amphotericin B and Budesonide which appears in Health Canada's list of Generic Drug Submissions Under Review, dated 2022-12-13.Organization: Health Canada
April 2023
Req # A-2022-001329
Building fire at 77 Westfield Road. Caledonia, Nova Scotia B0T 1B0. Date October 26, 2022. The written report of what happened.Organization: Health Canada
April 2023
Req # A-2022-001346
All records related to meetings between Canadian not-for-profit "Dying with Dignity Canada" and Health Canada officials between March 2020 and January 19, 2023.Organization: Health Canada
April 2023
Req # A-2022-001443
Product names and number of requests for each product requested through the Special Access Program during calendar years 2017, 2021, 2022.Organization: Health Canada
April 2023